Skip to main content
ABT
NYSE Life Sciences

Abbott Beats Q2 Estimates, Raises Full-Year Profit Outlook

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$91.437
Mkt Cap
$155.492B
52W Low
$81.97
52W High
$137.49
52W Position info
12% above low
Off High info
33% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ABT is trading near its 52-week low of $81.97 (12% above the low).

Summary

Abbott delivered a Q2 beat with adjusted EPS of $1.31 versus the $1.28 consensus, driven by 8.4% comparable growth in medical devices, including strength in electrophysiology and diabetes care. Revenue rose 13% reported to $12.6 billion, though nutrition sales slipped 3.6% on a comparable basis. Management raised full-year adjusted EPS guidance to $5.45-$5.60 from $5.38-$5.58 and set Q3 guidance at $1.38-$1.46. The company returned $2.1 billion to shareholders through dividends and buybacks. This follows the June 29 DOJ decision to drop its criminal investigation into the baby formula business, removing a key overhang. The raised guidance and device momentum suggest the Exact Sciences integration is progressing well.

At the time of this announcement, ABT was trading at $91.44 on NYSE in the Life Sciences sector, with a market capitalization of approximately $155.5B. The 52-week trading range was $81.97 to $137.49. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ABT - Latest Insights

ABT
Oct 21, 2026, 8:53 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $98.21
Real-time Price: $109.40 info
Change: +$11.19 (+11%) info
Market Cap: $189.304B info
ABT
Oct 21, 2026, 7:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $99.52
Real-time Price: $109.40 info
Change: +$9.88 (+10%) info
Market Cap: $189.304B info
ABT
Oct 21, 2026, 7:32 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $100.55
Real-time Price: $109.40 info
Change: +$8.85 (+9%) info
Market Cap: $189.304B info
ABT
Oct 21, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $100.52
Real-time Price: $109.40 info
Change: +$8.88 (+9%) info
Market Cap: $189.304B info
ABT
Oct 05, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $97.53
Real-time Price: $109.40 info
Change: +$11.87 (+12%) info
Market Cap: $189.304B info